.Pharmacolibrary.Drugs.ATC.J.J05AE09 .Pharmacolibrary.Drugs.ATC.J.J05AE09| name: | Tipranavir | |
| ATC code: | J05AE09 | route: | oral |
| compartments: | 2 | |
| dosage: | 500 | mg |
| volume of distribution: | 7.5 | L |
| clearance: | 8.1 | L/h |
| other parameters in model implementation | ||
Tipranavir is a non-peptidic protease inhibitor used in combination with ritonavir for the treatment of HIV-1 infection in treatment-experienced adult patients. It is approved for use in several countries, but its use has declined in favor of other newer antiretrovirals.
Population pharmacokinetic analysis in HIV-infected adults, administered orally with ritonavir boosting.
(2006). Tipranavir: PNU 140690, tipranivir. Drugs in R&D 7(1) 55–62. DOI:10.2165/00126839-200607010-00005 PUBMED:https://pubmed.ncbi.nlm.nih.gov/16620137